According to a report by Reports and Data, the global Kidney Function Test market size is expected to reach USD 1,440.1 million by 2030 with a revenue CAGR of 6.3% over the forecast period.

The increase in awareness about diagnostic methods in various hospitals, clinics, and other healthcare centers is expected to drive market revenue growth during the forecast period. The rising prevalence of various kidney illnesses has led to the use of kidney function testing.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/1448

One of the key factors driving demand for kidney function tests is the rising prevalence of renal failure caused by sedentary lifestyles, bad eating habits, excessive alcohol consumption, diabetes, hypertension, and obesity.

The increasing geriatric population, rising need for kidney function tests to cater to kidney dysfunctions, and improving healthcare systems and diagnostic centers are important factors driving market revenue growth.

In addition, increasing government initiatives for the treatment of kidney disease are expected to boost revenue growth of the market. Public-private alliances are making kidney disease diagnostics more accessible. For example, the National Kidney Foundation (NKF) and the National Committee for Quality Assurance (NCQA) have issued a new kidney health evaluation measure for diabetes patients in July 2020. Diabetic patients should be examined for kidney diseases on a regular basis, according to the new guidelines. These guidelines are expected to create a suitable environment for market revenue growth.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/1448

However, stringent government regulations governing the use of specific methods in kidney tests may hamper the market revenue growth. Kidney is a very essential organ of a human body and to examine any Chronic Kidney Disease (CKD) in an individual, kidney test function is needed. Hence, the function test has to follow many strict government regulations and also undergo strict regulations for approval. For example, if a patient has a CKD and needs to undergo kidney transplant, the patient as well as the hospitals need to follow proper documentations or bonds under the laws of the government, which might be challenging.

The report highlights some key segments of the market. The dipstick segment is expected to account for the largest market share in the global kidney function test market over the forecast period, owing to its capacity to detect ketones, blood, glucose, urobilinogen, nitrite, and proteins, as well as cost-effectiveness.

The diagnostic laboratories segment is expected to register a faster CAGR during the forecast period because testing in these labs is less expensive, can perform a wide range of tests, and provide exact findings. The urine test segment is expected to register steady revenue growth over the forecast period. These tests are inexpensive and frequently used to diagnose bladder infections, diabetes, and kidney stones.

The kidney function test market in North America is expected to account for the largest revenue share in the global market over the forecast period. The availability of technologically improved goods, a well-developed healthcare infrastructure, and an increase in the prevalence of severe disorders are factors driving market growth. In addition, rising diabetes and hypertension incidence, excessive alcohol use, increased public awareness, and advantageous reimbursement scenarios, are all contributing to market expansion in this region.

Some of the key companies profiled in the report include Abbott Laboratories, Danaher Corporation, Siemens Healthcare GmbH, Sysmex Corporation, Randox Laboratories Ltd., Baxter International Inc., F. Hoffmann-La Roche Ltd., Arkray, Inc., Acon Laboratories Inc., and Quest Diagnostics Incorporated.

The report segments the global kidney function test market based on type, product, end use, and region. The type segment includes dipsticks, reagents, and disposables. The product segment includes urine tests and blood tests. The end-use segment includes hospitals and clinics, academic research laboratories, and diagnostic laboratories. The regional segment includes North America, Europe, Asia-Pacific, Latin America, and the Middle East.

Request customization of the report @

https://www.reportsanddata.com/request-customization-form/1448

Thank you for reading our report. Please connect with us to know more about the report and its customization feature. Our team will ensure the report is well suited to meet your requirements.

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse for more reports…

https://www.reportsanddata.com/report-detail/long-term-care-services-market

https://www.reportsanddata.com/report-detail/drug-delivery-devices-market